スポンサーリンク
First Department of Internal Medicine Nagoya university School of Medicine | 論文
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- Two Entities of Precursor T-Cell Lymphoblastic Leukemia/Lymphoma Based on Radiologic and Immunophenotypic Findings
- EBV-Positive Burkitt Lymphoma as a Late-Onset Posttransplantion Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation
- PJ-778 Clinical Utility of Very Low Concentrations of Cardiac Troponin T after Additional Treatment in Patients with Chronic Heart Failure(PJ131,Heart Failure (Laboratory/Biomarkers) 2 (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of Th
- PJ-250 Prognostic Utility of Combination of BNP and GFR on Admission in Patients who Underwent Emergent Coronary Angiography for ACS(PJ042,ACS/AMI (Clinical/Diagnosis) 1 (IHD),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Ci
- DPJ-020 Cystatin-C and Cardiac Mortality in Patients Admitted for Worsening Chronic Heart Failure with Normal to Moderately Impaired Renal Function(DPJ04,Heart Failure (Diagnosis) (M),Digital Poster Session (Japanese),The 73rd Annual Scientific Meeting of
- DPJ-019 Prognostic Value of Multi-biomarker Approach Using BNP, Troponin T and GFR after Additional Treatment in Patients with Chronic Heart Failure(DPJ04,Heart Failure (Diagnosis) (M),Digital Poster Session (Japanese),The 73rd Annual Scientific Meeting o
- OJ-107 Prognostic Value of Cystatin-C versus Estimated GFR after Additional Treatment in Patients with Chronic Heart Failure without Advanced Renal Impairment(OJ18,Heart Failure (Laboratory/Biomarkers) (M),Oral Presentation (Japanese),The 73rd Annual Scie
- OJ-104 Clinical Utility of Very Low Concentrations of Troponin T on Admission in Patients Hospitalized for Worsening Chronic Heart Failure(OJ18,Heart Failure (Laboratory/Biomarkers) (M),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of Th
- OJ-103 Prognostic Utility of Multi-biomarker Approach Using NT-proBNP, Troponin T and GFR in Patients Hospitalized for Worsening Chronic Heart Failure(OJ18,Heart Failure (Laboratory/Biomarkers) (M),Oral Presentation (Japanese),The 73rd Annual Scientific M
- OJ-066 Clinical Utility of Very Low Serum Concentrations of Cardiac Troponin T on Admission in Patients with Acute Coronary Syndrome(OJ11,ACS/AMI (Clinical/Diagnosis) (IHD),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Ci
- PJ-917 Prognostic Utility of Multi-biomarker Approach Using NT-proBNP, Cardiac Troponin T and Cystatin-C after Additional Treatment in Patients with CHF(Neurohumoral factors(02)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanes
- PJ-895 Prognostic Utility of Combination of Cardiac Troponin T and BNP in End-Stage Renal Disease : 8-Year Outcome Analysis(Kidney / Renal circulation(08)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-164 Utility of NT-proBNP as Screening for Cardiovascular Disease (CVD) in Health Checkup Examination(Preventive medicine/Epidemiology/Education(05)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-129 Prognostic Value of Cystatin-C versus Estimated GFR by MDRD Equation after Additional Treatment in Patients with Chronic Heart Failure(Heart failure, clinical(14)(M),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circul
- PJ-128 Cystatin-C and In-hospital Mortality in Patients Admitted for Worsening Chronic Heart Failure(Heart failure, clinical(14)(M),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- PE-091 Prognostic Utility of Combination of NT-proBNP and Troponin T in Patients Hospitalized for Worsening CHF with Preserved LV Systolic Function(Heart failure, clinical(07)(M),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese C
- OE-019 Pentraxin 3, a New Inflammatory Marker, is Useful for Predicting 6-Month Cardiac Event in Patients with ACS(Acute coronary syndrome, basic/clinical(01)(IHD),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation S
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Vagal Modification Can Also Help Prevent Late Recurrence of Atrial Fibrillation After Segmental Pulmonary Vein Isolation
スポンサーリンク